Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 167Carcinoma, Non-Small-Cell Lung 111Lung Neoplasms 54Hodgkin Disease 22Neoplasm Metastasis 17Recurrence 15Lymphoma 15Triple Negative Breast Neoplasms 14Neoplasms 14Prostatic Neoplasms 10Adenocarcinoma of Lung 10Sarcoma 9Rhabdomyosarcoma 9Uterine Cervical Neoplasms 8Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 6Small Cell Lung Carcinoma 5Ovarian Neoplasms 5Mesothelioma, Malignant 5Breast Neoplasms, Male 5Brain Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4NSCLC 4Multiple Myeloma 4Unspecified Adult Solid Tumor, Protocol Specific 3Mesothelioma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

Cyclophosphamide 65Peripheral Blood Stem Cell Transplantation 37fludarabine phosphate 36Doxorubicin 31Etoposide 30Vincristine 29Whole-Body Irradiation 28Rituximab 26Prednisone 26Brentuximab Vedotin 26Mycophenolic Acid 25Filgrastim 22Cyclosporine 22Methotrexate 20Busulfan 19Cytarabine 18Radiotherapy 17Antilymphocyte Serum 16Tacrolimus 15Melphalan 15Carboplatin 14Ifosfamide 13Bortezomib 13Methylprednisolone 12Gemcitabine 11Flow Cytometry 10Lenalidomide 9Dexamethasone 9romidepsin 8Vorinostat 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Anaplastic × Vinorelbine × Clear all
NCT03443128 2025-02-13

Vinorelbine for Recurrent ALCL-2017

Children's Cancer Group, China

Phase 2 Completed
20 enrolled
Lymphoid

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT03397953 2022-07-26

Vinorelbine for Recurrent ACLC

Children's Cancer Group, China

Phase 2 Completed
20 enrolled
Lymphoid

Recurrence, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡